Editorial Board Member - JSCCP
Dr. Jonathan Keller obtained his Ph.D. at George Washington University, Washington, D.C., where he characterized and purified interleukin 3. He is currently a Principal Investigator in the Center for Cancer Research, National Cancer Institute-Frederick, Frederick, Md, where he is the Head of the Hematopoiesis and Stem Cell Biology Section in the Mouse Cancer Genetics Program. He is also an Adjunct Professor in the Genetics Department at the George Washington University, Washington, D.C. He has authored numerous manuscripts, holds three patents, and has received awards for his scientific accomplishments in the area of molecular and cellular regulation of hematopoietic cell growth and differentiation.
Dr. Jonathan Keller has a long standing interest in defining the molecular and cellular regulation of hematopoiesis. He characterized and purified interleukin 3, one of the first growth factors that regulate hematopoietic stem cell (HSC) development. He discovered that the proliferation of HSC is balanced by the action of negative growth regulators including transforming growth factor-β. His laboratory is currently focused on understanding how transcription factors regulate HSC quiescence, survival, self-renewal, and cell fate, and how they are integrated into wider transcription factor regulatory networks that regulate HSC development.
Dr. Jonathan Keller's areas of expertise includes: 1) Stem Cell Biology 2) Hematopoiesis 3) Transcription Factors 4) Hematopoietic malignancies 5) Molecular regulation of self renewal and cell fate 6) Bone marrow transplantation.
Other Editorial Board Members - JSCCP
Department Of Medicine
University of Connecticut Health Center
Department of Medical Genetics
University of British Colombia
School of Medicine
Department of Neurosurgery SUNY Upstate Medical University
Department of Orthopedics
CHA Bundang Medical Center
Department of Radiology
University of Washington School of Medicine
Department of Immunology
Cancer Gene Therapy Research Center
Zanjan University of Medical Sciences
Lee Gil Ya Cancer and Diabetes Institute
Department of Neurosurgery
University Medical Center Hamburg-Eppendorf